Be The First to Receive Breaking News
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study
Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.